Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

BACKGROUND: Ipilimumab improves the survival of metastatic melanoma patients. Despite documented, durable objective responses, a significant number of patients fails to benefit from treatment. The aim of this study was to identify an upfront marker for treatment benefit. METHODS: A total of 187 meta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Ferrucci, P F, Gandini, S, Battaglia, A, Alfieri, S, Di Giacomo, A M, Giannarelli, D, Cappellini, G C Antonini, De Galitiis, F, Marchetti, P, Amato, G, Lazzeri, A, Pala, L, Cocorocchio, E, Martinoli, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580390/
https://ncbi.nlm.nih.gov/pubmed/26010413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.180
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados